Citation 85932

FU,B: YANG,L: YANG,XP: LI,XP: JIA,ZJ:. (2000). NEW BISABOLANE SESQUITERPENES FROM LIGULARIA SONGARICA.. 55(12)

Citation Details

Title	NEW BISABOLANE SESQUITERPENES FROM LIGULARIA SONGARICA.
Authors	FU,B: YANG,L: YANG,XP: LI,XP: JIA,ZJ:
Year	2000
Volume	55
Issue	12

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Ligularia songarica (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	None
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-8-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	None
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-8-ANGELOYL-OXY-2-BETA-3-BETA-EPOXY-10-HYDROXY-11-ISO-PROPOXY:	INACTIVE
24	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	None
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
30	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,4-BETA-ACETOXY-5-BETA-8-DIANGELOYL-OXY-10-11-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
35	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	None
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	ACTIVE
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
44	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
45	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-11-DIANGELOYL-OXY-8-10-DIHYDROXY-2-BETA-3-BETA-EPOXY:	INACTIVE
46	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	None
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	ACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	ACTIVE
49	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
50	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
51	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
56	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-3-BETA-ISO-BUTYRYL-OXY-2-BETA-8-11-TRIHYDROXY:	INACTIVE
57	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	None
58	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	ACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	ACTIVE
60	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
61	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
62	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
64	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
65	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
66	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE,5-BETA-ACETOXY-4-BETA-10-DIANGELOYL-OXY-2-BETA-3-BETA-8-11-TETRAHYDROXY:	INACTIVE
68	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDTLC DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	None
69	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE
70	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE
71	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	INACTIVE
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	INACTIVE
73	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	INACTIVE
74	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE
75	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	INACTIVE
76	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE
77	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE
78	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BISABOL-7(14)-ENE-4-ONE,5-ALPHA-ACETOXY-2-ALPHA-3-BETA-DIANGELOYL-OXY-8-12-DIHYDROXY-10-11-EPOXY:	ACTIVE

Citation 85932

Citation Details

Summary

Organisms and Their Experiments (1)

Ligularia songarica (ASTERACEAE)

Show SPARQL Queries (1)

Query 1